Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CStone Pharmaceuticals
  6. News
  7. Summary
    2616   KYG2588M1006

CSTONE PHARMACEUTICALS

(2616)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China

11/21/2021 | 07:50pm EST


ę MT Newswires 2021
All news about CSTONE PHARMACEUTICALS
01/19CStone announced two key phase 3 registrational clinical trials of sugemalimab complete..
AQ
01/19EQRx, Inc. and CStone Pharmaceuticals Announce Sugemalimab Demonstrates Statistically S..
CI
01/18CStone Pharma Says Lung Cancer Treatment Improves Overall Survival of Patients in Clini..
MT
01/18CStone announces the GEMSTONE-302 study of sugemalimab met the endpoint of overall surv..
PR
01/18CStone Pharmaceuticals Announces Gemstone-302 Study of Sugemalimab Met the Endpoint of ..
CI
01/17CStone Pharma Completes Patient Enrollment for Two Key Studies of Cancer Drug; Shares J..
MT
01/17CStone Pharmaceuticals Announces Two Key Phase 3 Registrational Clinical Trials of Suge..
CI
01/16CStone Pharma's Lung Cancer Treatment Featured in Medical Journal
MT
01/14CStone Pharmaceuticals Announces the Clinical Data from Registrational Study of Sugemal..
CI
01/14Cstone Pharmaceuticals Announces the Registrational Clinical Study Results of Sugemalim..
CI
More news
Financials
Sales 2021 254 M 40,0 M 40,0 M
Net income 2021 -1 811 M -285 M -285 M
Net cash 2021 1 652 M 260 M 260 M
P/E ratio 2021 -3,69x
Yield 2021 -
Capitalization 5 882 M 924 M 925 M
EV / Sales 2021 16,6x
EV / Sales 2022 3,91x
Nbr of Employees 573
Free-Float 75,0%
Chart CSTONE PHARMACEUTICALS
Duration : Period :
CStone Pharmaceuticals Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSTONE PHARMACEUTICALS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 5,05 CNY
Average target price 13,00 CNY
Spread / Average Target 157%
EPS Revisions
Managers and Directors
Ning Jun Jiang Chairman & Chief Executive Officer
Jian Xin Yang Chief Medical Officer & Senior Vice President
Xin Zhong Wang Chief Scientific Officer & Senior Vice President
Ting Yuk Wu Independent Non-Executive Director
Hong Bin Sun Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSTONE PHARMACEUTICALS-25.27%965
GILEAD SCIENCES, INC.-7.26%84 470
REGENERON PHARMACEUTICALS-4.16%63 282
VERTEX PHARMACEUTICALS3.18%57 608
WUXI APPTEC CO., LTD.-12.95%47 873
BIONTECH SE-37.66%38 812